Drug intelligence / Profile preview

Castanospermine

Development stage
Preclinical
Lead developer
60 Degrees Pharmaceuticals
Modality
Small Molecules
Administration
Oral, Intraperitoneal
01

Overview

Castanospermine is a natural indolizidine alkaloid isolated from the seeds of the Australian black bean or Moreton Bay chestnut tree (Castanospermum australe). It functions as a potent inhibitor of various glucosidase enzymes, including lysosomal alpha- and beta-glucosidases, and endoplasmic reticulum (ER) alpha-glucosidases I and II. This inhibition disrupts the processing of N-linked oligosaccharides, which can lead to the misfolding of viral envelope glycoproteins, thereby impairing viral maturation and infectivity. Additionally, castanospermine exhibits anti-inflammatory, immunosuppressive, and anti-metastatic activities, and has been shown to inhibit cyclooxygenase.

Other names
1,6,7,8-tetrahydroxyoctahydroindolizineCastinospermine
02

Targets

GAA (Lysosomal acid alpha-glucosidase)Sucrase-IsomaltaseGBA1 (Glucosylceramidase)GluI (Endoplasmic reticulum alpha-glucosidase I)BXL (Beta-xylosidase)BGL (beta-Glucosidase)

Beyond the preview

Go deeper on Castanospermine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Castanospermine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call